March 13, 2023
Zealand Pharma Provides Statement on Silicon Valley Bank Closure
Company announcement – No. 5 / 2023 Zealand Pharma Provides Statement on Silicon Valley Bank Closure Copenhagen, Denmark March 12,…
Pharmaceuticals, Biotechnology and Life Sciences
Company announcement – No. 5 / 2023 Zealand Pharma Provides Statement on Silicon Valley Bank Closure Copenhagen, Denmark March 12,…
ENCINITAS, Calif., March 11, 2023 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), has learned that Silicon Valley Bank…
Conference Call on Monday, March 13, 2023 at 8:30 a.m. ETLEXINGTON, Mass., March 11, 2023 (GLOBE NEWSWIRE) — Agenus (Nasdaq:…
OKLAHOMA CITY, March 11, 2023 (GLOBE NEWSWIRE) — Cytovance Biologics, Inc. (Cytovance Biologics), a biopharmaceutical contract development and manufacturing organization…
BOSTON, March 10, 2023 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and…
VANCOUVER, British Columbia, March 10, 2023 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (the “Company”) (TSXV:RKV) announces that it may apply…
LOS ANGELES, March 10, 2023 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us”), a biopharmaceutical…
CAMBRIDGE, Mass., March 10, 2023 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering…
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 10, 2023 (GLOBE…
SAN DIEGO and TORONTO, March 10, 2023 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (Nasdaq: APTO; TSX:…